{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "1c27bc53",
   "metadata": {},
   "outputs": [],
   "source": [
    "from dotenv import load_dotenv\n",
    "import os\n",
    "from pydantic import BaseModel\n",
    "from langchain_openai import OpenAI  \n",
    "from langchain.agents import initialize_agent, AgentType\n",
    "from langchain.tools import StructuredTool\n",
    "from neo4j import GraphDatabase\n",
    "from langchain_neo4j import Neo4jGraph, GraphCypherQAChain\n",
    "from langchain_openai import ChatOpenAI\n",
    "from langchain_core.prompts.prompt import PromptTemplate\n",
    "#from langchain_community.graphs import Neo4jGraph\n",
    "import traceback\n",
    "from concurrent.futures import ThreadPoolExecutor, TimeoutError as FutureTimeoutError\n",
    "import requests\n",
    "import fitz "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "0fe0e03e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# --- Get OpenAI key\n",
    "\n",
    "load_dotenv()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "c2238187",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " Connected to Neo4j!\n",
      "[{'n': {'gender': 'F', 'reportDate': neo4j.time.Date(2021, 8, 27), 'ageUnit': 'YR', 'reporterOccupation': 'Physician', 'primaryid': 100654764, 'age': 56.0, 'eventDate': neo4j.time.Date(2014, 3, 25)}}, {'n': {'gender': 'F', 'reportDate': neo4j.time.Date(2021, 9, 13), 'ageUnit': 'YR', 'reporterOccupation': 'Physician', 'primaryid': 101678656, 'age': 53.0, 'eventDate': neo4j.time.Date(2014, 5, 3)}}, {'n': {'gender': 'M', 'reportDate': neo4j.time.Date(2021, 8, 25), 'ageUnit': 'YR', 'reporterOccupation': 'Hospital', 'primaryid': 101980392, 'age': 77.0, 'eventDate': neo4j.time.Date(2010, 12, 27)}}, {'n': {'gender': 'M', 'reportDate': neo4j.time.Date(2021, 7, 20), 'ageUnit': 'YR', 'reporterOccupation': 'Hospital', 'primaryid': 103011729, 'age': 60.0, 'eventDate': neo4j.time.Date(2013, 6, 14)}}, {'n': {'gender': 'M', 'reportDate': neo4j.time.Date(2021, 9, 25), 'ageUnit': 'YR', 'reporterOccupation': 'Pharmacist', 'primaryid': 103829296, 'age': 31.0, 'eventDate': neo4j.time.Date(2014, 3, 25)}}]\n"
     ]
    }
   ],
   "source": [
    "\n",
    "# --- Neo4j Tool\n",
    "NEO4J_URI=\"bolt://3.95.30.19\"\n",
    "NEO4J_USERNAME=\"neo4j\"\n",
    "NEO4J_PASSWORD=\"departures-octobers-justice\"\n",
    "NEO4J_DATABASE=\"neo4j\"\n",
    "\n",
    "URI = \"bolt://44.192.43.48:7687\"\n",
    "AUTH = (\"neo4j\", \"deeds-combs-rays\")\n",
    "driver = GraphDatabase.driver(NEO4J_URI, auth=(NEO4J_USERNAME, NEO4J_PASSWORD))\n",
    "driver.verify_connectivity()\n",
    "print(\" Connected to Neo4j!\")\n",
    "with driver.session() as session:\n",
    "    results = session.run(\"MATCH (n) RETURN n LIMIT 5\").data()\n",
    "print(results)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "1beddfc2",
   "metadata": {},
   "outputs": [],
   "source": [
    "# def get_schema(tx):\n",
    "#     # Consulta para pegar os tipos de n√≥s e relacionamentos\n",
    "#     result = tx.run(\"\"\"\n",
    "#         CALL db.schema.visualization()\n",
    "#     \"\"\")\n",
    "#     return result.single()\n",
    "\n",
    "# with driver.session() as session:\n",
    "#     schema = session.read_transaction(get_schema)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "758e1d37",
   "metadata": {},
   "outputs": [],
   "source": [
    "# # https://python.langchain.com/docs/integrations/graphs/neo4j_cypher/\n",
    "\n",
    "# graph = Neo4jGraph(\n",
    "#     url=NEO4J_URI,\n",
    "#     username=NEO4J_USERNAME,\n",
    "#     password=NEO4J_PASSWORD\n",
    "# )\n",
    "\n",
    "# # Get Neo4j Database Schema\n",
    "# schema = graph.schema\n",
    "# print(graph.schema)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "f4958717",
   "metadata": {},
   "outputs": [],
   "source": [
    "# # Get Neo4j Database Schema\n",
    "# schema = graph.schema\n",
    "\n",
    "# # Seu prompt original para gera√ß√£o de Cypher\n",
    "# CYPHER_GENERATION_PROMPT = PromptTemplate(\n",
    "#     input_variables=[\"schema\", \"question\"],\n",
    "#     template=\"\"\"Task:Generate Cypher statement to query a graph database.\n",
    "# Instructions:\n",
    "# Use only the provided relationship types and properties in the schema.\n",
    "# Do not use any other relationship types or properties that are not provided.\n",
    "# After identifying the drug to which the question is related to, capitalize all letters of it.\n",
    "\n",
    "# Schema:\n",
    "# {schema}\n",
    "\n",
    "# Write multiple Cypher queries , corresponding to all of the possible paths between nodes, if multiple are possible.\n",
    "# Example - connecting Manufacturer with Drug:\n",
    "# 1) (m:Manufacturer)-[:REGISTERED]->(c:Case)-[:IS_PRIMARY_SUSPECT]->(d:Drug)\n",
    "# 2) (m:Manufacturer)-[:REGISTERED]->(c:Case)-[:IS_CONCOMITANT]->(d:Drug)\n",
    "# 3) (m:Manufacturer)-[:REGISTERED]->(:Case)-[:IS_SECONDARY_SUSPECT]->(:Drug)\n",
    "\n",
    "# Note: Do not include any explanations or apologies in your responses.\n",
    "# Do not respond to any questions that might ask anything else than for you to construct a Cypher statement.\n",
    "# Do not include any text except the generated Cypher statement.\n",
    "\n",
    "# The question is:\n",
    "# {question}\"\"\"\n",
    "# )\n",
    "\n",
    "# # Prompt para gera√ß√£o da resposta com contexto\n",
    "# QA_PROMPT = PromptTemplate(\n",
    "#     input_variables=[\"question\", \"context\"],\n",
    "#     template=\"\"\"\n",
    "# Use apenas as informa√ß√µes em 'context' para responder.\n",
    "# Se 'context' estiver vazio, responda: \"N√£o sei\".\n",
    "\n",
    "# Context:\n",
    "# {context}\n",
    "\n",
    "# Pergunta: {question}\n",
    "# Resposta:\"\"\",\n",
    "# )\n",
    "\n",
    "# # Inicializa o chain com os ajustes:\n",
    "# chain = GraphCypherQAChain.from_llm(\n",
    "#     cypher_llm=ChatOpenAI(temperature=0, model=\"gpt-4.1-nano-2025-04-14\"),\n",
    "#     qa_llm=ChatOpenAI(temperature=0, model=\"gpt-4.1-nano-2025-04-14\"),\n",
    "#     graph=graph,\n",
    "#     verbose=True,\n",
    "#     cypher_prompt=CYPHER_GENERATION_PROMPT,\n",
    "#     qa_prompt=QA_PROMPT,\n",
    "#     allow_dangerous_requests=True,\n",
    "#     return_direct=True, # Avoids model from replying idk even if it gets right context\n",
    "#     return_intermediate_steps=True,\n",
    "#     top_k=10, # Limits results,\n",
    "#     validate_cypher=True  # Prevents wrongful cypher syntax/queries\n",
    "# )\n",
    "\n",
    "# # Executa a consulta\n",
    "# question = \"Which manufacturers are connected to drugs which contain furoSemide in its name?\"\n",
    "# result = chain.invoke({\"query\": question})\n",
    "\n",
    "# # Outputs\n",
    "# print(\"üëâ Result completo:\")\n",
    "# print(result)\n",
    "\n",
    "# print(\"\\nüîπ Intermediate steps:\")\n",
    "# for step in result[\"intermediate_steps\"]:\n",
    "#     print(step)\n",
    "\n",
    "# print(\"\\n‚úÖ Result direto (lista JSON):\")\n",
    "# print(result[\"result\"])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "8bd95705",
   "metadata": {},
   "outputs": [],
   "source": [
    "# --- Neo4j Tool\n",
    "NEO4J_URI=\"bolt://3.95.30.19\"\n",
    "NEO4J_USERNAME=\"neo4j\"\n",
    "NEO4J_PASSWORD=\"departures-octobers-justice\"\n",
    "NEO4J_DATABASE=\"neo4j\"\n",
    "\n",
    "# URI = \"bolt://44.192.43.48:7687\"\n",
    "# AUTH = (\"neo4j\", \"deeds-combs-rays\")\n",
    "# driver = GraphDatabase.driver(NEO4J_URI, auth=(NEO4J_USERNAME, NEO4J_PASSWORD))\n",
    "# driver.verify_connectivity()\n",
    "# print(\" Connected to Neo4j!\")\n",
    "# with driver.session() as session:\n",
    "#     results = session.run(\"MATCH (n) RETURN n LIMIT 5\").data()\n",
    "# print(results)\n",
    "\n",
    "# Connect to Neo4j DB\n",
    "graph = Neo4jGraph(\n",
    "        url=NEO4J_URI,\n",
    "        username=NEO4J_USERNAME,\n",
    "        password=NEO4J_PASSWORD\n",
    "    )\n",
    "\n",
    "# Get Neo4j Database Schema\n",
    "schema = graph.schema\n",
    "\n",
    "# Seu prompt original para gera√ß√£o de Cypher\n",
    "CYPHER_GENERATION_PROMPT = PromptTemplate(\n",
    "    input_variables=[\"schema\", \"question\"],\n",
    "    template=\"\"\"Task:Generate Cypher statement to query a graph database.\n",
    "    Instructions:\n",
    "    Use only the provided relationship types and properties in the schema.\n",
    "    Do not use any other relationship types or properties that are not provided.\n",
    "    After identifying the drug to which the question is related to, capitalize all letters of it.\n",
    "\n",
    "    Schema:\n",
    "    {schema}\n",
    "\n",
    "    Write multiple Cypher queries , corresponding to all of the possible paths between nodes, if multiple are possible.\n",
    "    Example - connecting Manufacturer with Drug:\n",
    "    1) (m:Manufacturer)-[:REGISTERED]->(c:Case)-[:IS_PRIMARY_SUSPECT]->(d:Drug)\n",
    "    2) (m:Manufacturer)-[:REGISTERED]->(c:Case)-[:IS_CONCOMITANT]->(d:Drug)\n",
    "    3) (m:Manufacturer)-[:REGISTERED]->(:Case)-[:IS_SECONDARY_SUSPECT]->(:Drug)\n",
    "\n",
    "    Note: Do not include any explanations or apologies in your responses.\n",
    "    Do not respond to any questions that might ask anything else than for you to construct a Cypher statement.\n",
    "    Do not include any text except the generated Cypher statement.\n",
    "\n",
    "    The question is:\n",
    "    {question}\"\"\"\n",
    "    )\n",
    "\n",
    "# Prompt para gera√ß√£o da resposta com contexto\n",
    "QA_PROMPT = PromptTemplate(\n",
    "    input_variables=[\"question\", \"context\"],\n",
    "    template=\"\"\"\n",
    "    Use apenas as informa√ß√µes em 'context' para responder.\n",
    "    Se 'context' estiver vazio, responda: \"N√£o sei\".\n",
    "\n",
    "    Context:\n",
    "    {context}\n",
    "\n",
    "    Pergunta: {question}\n",
    "    Resposta:\"\"\",\n",
    "    )\n",
    "\n",
    "# Inicializa o chain com os ajustes:\n",
    "chain = GraphCypherQAChain.from_llm(\n",
    "    cypher_llm=ChatOpenAI(temperature=0, model=\"gpt-4.1-nano-2025-04-14\"),\n",
    "    qa_llm=ChatOpenAI(temperature=0, model=\"gpt-4.1-nano-2025-04-14\"),\n",
    "    graph=graph,\n",
    "    verbose=True,\n",
    "    cypher_prompt=CYPHER_GENERATION_PROMPT,\n",
    "    qa_prompt=QA_PROMPT,\n",
    "    allow_dangerous_requests=True,\n",
    "    return_direct=True, # Avoids model from replying idk even if it gets right context\n",
    "    return_intermediate_steps=True,\n",
    "    top_k=10, # Limits results,\n",
    "    validate_cypher=True,  # Prevents wrongful cypher syntax/queries\n",
    "    timeout=10 # Raises connection timeouts\n",
    "    )\n",
    "\n",
    "\n",
    "class Neo4jQueryInput(BaseModel):\n",
    "    question: str\n",
    "\n",
    "from concurrent.futures import ThreadPoolExecutor, TimeoutError as FutureTimeoutError\n",
    "\n",
    "def query_neo4j(question: str) -> str:\n",
    "    return chain.invoke({\"query\": question})\n",
    "\n",
    "\n",
    "neo4j_tool = StructuredTool.from_function(\n",
    "    func=query_neo4j,\n",
    "    name=\"Neo4jTool\",\n",
    "    description=\"\"\"Answers questions about the Neo4j Healthcare Analytics template,\n",
    "                   which contains information about Drugs, Manufacturers, Therapies, Outcomes, and Reactions.\n",
    "                   After identifying the drug to which the question is related to, capitalize all letters of it. Example: furosemide -> FUROSEMIDE this is Very Important!!! \n",
    "                   Example question: Which manufacturers are connected to drugs that contain Furosemide in its name?\n",
    "                   \n",
    "                   Output Restrictions:\n",
    "                   The queries are limited to 10 results, for cost management purposes.\"\"\",\n",
    "    args_schema=Neo4jQueryInput,\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "02b04e54",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Node properties:\n",
      "Drug {primarySubstabce: STRING, name: STRING}\n",
      "Case {reporterOccupation: STRING, gender: STRING, eventDate: DATE, reportDate: DATE, primaryid: INTEGER, age: FLOAT, ageUnit: STRING}\n",
      "Reaction {description: STRING}\n",
      "ReportSource {code: STRING, name: STRING}\n",
      "Outcome {outcome: STRING, code: STRING}\n",
      "Therapy {primaryid: INTEGER}\n",
      "Manufacturer {manufacturerName: STRING}\n",
      "AgeGroup {ageGroup: STRING}\n",
      "Relationship properties:\n",
      "IS_PRIMARY_SUSPECT {indication: STRING, doseAmount: STRING, doseUnit: STRING, drugSequence: STRING, route: STRING}\n",
      "IS_SECONDARY_SUSPECT {indication: STRING, doseAmount: STRING, doseUnit: STRING, drugSequence: STRING, route: STRING}\n",
      "IS_CONCOMITANT {indication: STRING, doseAmount: STRING, doseUnit: STRING, drugSequence: STRING, route: STRING}\n",
      "IS_INTERACTING {route: STRING, indication: STRING, doseAmount: STRING, doseUnit: STRING, drugSequence: STRING}\n",
      "PRESCRIBED {drugSequence: STRING, endYear: STRING, startYear: STRING}\n",
      "The relationships:\n",
      "(:Case)-[:RECEIVED]->(:Therapy)\n",
      "(:Case)-[:FALLS_UNDER]->(:AgeGroup)\n",
      "(:Case)-[:RESULTED_IN]->(:Outcome)\n",
      "(:Case)-[:HAS_REACTION]->(:Reaction)\n",
      "(:Case)-[:REPORTED_BY]->(:ReportSource)\n",
      "(:Case)-[:IS_PRIMARY_SUSPECT]->(:Drug)\n",
      "(:Case)-[:IS_CONCOMITANT]->(:Drug)\n",
      "(:Case)-[:IS_SECONDARY_SUSPECT]->(:Drug)\n",
      "(:Case)-[:IS_INTERACTING]->(:Drug)\n",
      "(:Therapy)-[:PRESCRIBED]->(:Drug)\n",
      "(:Manufacturer)-[:REGISTERED]->(:Case)\n"
     ]
    }
   ],
   "source": [
    "print(graph.schema)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "0ff4563e",
   "metadata": {},
   "outputs": [],
   "source": [
    "# --- Adverse Events Tool\n",
    "\n",
    "def get_adverse_events(drug_name: str, limit: int = 100) -> str:\n",
    "    drug_name = drug_name.upper()\n",
    "    url = f\"https://api.fda.gov/drug/event.json?search=patient.drug.medicinalproduct:{drug_name}&limit={limit}\"\n",
    "    response = requests.get(url)\n",
    "    data = response.json()\n",
    "\n",
    "    adverse_effects_counter = {}\n",
    "    for patient in data.get(\"results\", []):\n",
    "        for reaction in patient[\"patient\"][\"reaction\"]:\n",
    "            name = reaction[\"reactionmeddrapt\"]\n",
    "            adverse_effects_counter[name] = adverse_effects_counter.get(name, 0) + 1\n",
    "\n",
    "    top_20 = sorted(adverse_effects_counter.items(), key=lambda x: x[1], reverse=True)[:10]\n",
    "    formatted = \"\\n\".join(f\"{effect}: {count}\" for effect, count in top_20)\n",
    "\n",
    "    return f\"Top 10 adverse effects for {drug_name}:\\n{formatted}\"\n",
    "\n",
    "class AdverseEventsInput(BaseModel):\n",
    "    drug_name: str\n",
    "\n",
    "adverse_events_tool = StructuredTool.from_function(\n",
    "    func=get_adverse_events,\n",
    "    name=\"AdverseEventsRetriever\",\n",
    "    description=\"Gets the top 10 FDA adverse events for a given drug name.\",\n",
    "    args_schema=AdverseEventsInput,\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "49cbdf3f",
   "metadata": {},
   "outputs": [],
   "source": [
    "def extract_text_from_pages(pdf_path:str, pages:list):\n",
    "    \"\"\"\n",
    "    Extracts plain text from specific pages in a PDF.\n",
    "\n",
    "    :param pdf_path: str ‚Äì path to your PDF file\n",
    "    :param pages: list of ints ‚Äì page numbers you want (1-based)\n",
    "    :return: dict mapping page number ‚Üí extracted text\n",
    "    \"\"\"\n",
    "    doc = fitz.open(pdf_path)\n",
    "    result = {}\n",
    "\n",
    "    for human_page in pages:\n",
    "        idx = human_page - 1  # convert to zero-based index\n",
    "        if idx < 0 or idx >= doc.page_count:\n",
    "            print(f\"‚ö†Ô∏è Page {human_page} out of range. Skipping.\")\n",
    "            continue\n",
    "\n",
    "        page = doc.load_page(idx)  # get the page\n",
    "        text = page.get_text(\"text\")  # extract plain text\n",
    "        result[human_page] = text\n",
    "\n",
    "    doc.close()\n",
    "    return result\n",
    "\n",
    "def financial_report():\n",
    "    # Extract text from main financial analysis pages in the 24/25 annual report (contains P&L)\n",
    "    financial_context = extract_text_from_pages(\"../docs/grunenthal-annual-report24-25.pdf\", [30,31,32])\n",
    "    return financial_context\n",
    "\n",
    "\n",
    "financial_report_tool = StructuredTool.from_function(\n",
    "    func=financial_report,\n",
    "    name=\"FinancialReportRetriever\",\n",
    "    description=\"Gets information about Grunenthal's financial report 24/25\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "5deca067",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Attempt 1 of 10...\n",
      "\n",
      "\n",
      "\u001b[1m> Entering new AgentExecutor chain...\u001b[0m\n",
      "\u001b[32;1m\u001b[1;3mAction:\n",
      "```json\n",
      "{\n",
      "  \"action\": \"FinancialReportRetriever\",\n",
      "  \"action_input\": {}\n",
      "}\n",
      "```\n",
      "\u001b[0m\n",
      "Observation: \u001b[38;5;200m\u001b[1;3m{30: \"30\\nGr√ºnenthal Report 2024/2025\\nSTRONG FINANCIAL PERFORMANCE \\nResilience and stability\\nGr√ºnenthal's financial performance in 2024 \\ndemonstrated resilience and stability, navigating \\nchallenges and capitalising on opportunities to \\nmaintain robust results. Despite the ongoing ge\\xad\\nneric erosion of Palexia‚Ñ¢, one of our key brands, \\nthree factors helped to offset this impact: the \\ngrowth of Qutenza‚Ñ¢, the strong development \\nof our established brands, and the continued \\nbolstering of our portfolio with strategic acqui\\xad\\nsitions, including Valinor Pharma and its product \\nMovantik‚Ñ¢.\\nOur brands continue to drive \\ngrowth\\nThe continuous growth of Qutenza‚Ñ¢ in the US \\nand European markets, as well as the solid per\\xad\\nformance of the Gr√ºnenthal Meds joint venture \\n(JV) and the remaining established brands port\\xad\\nfolio, reinforced Gr√ºnenthal‚Äôs growth. The decline \\nin sales of Palexia‚Ñ¢ continued to slow, supporting \\nthe belief that Palexia‚Äôs‚Ñ¢ performance will stabi\\xad\\nlise, akin to the performance of other late-stage \\nbrands of the type and size of Palexia‚Ñ¢.\\nFinancial flexibility and operational \\nachievements\\nOur adjusted EBITDA for 2024 was ‚Ç¨\\u2009412 \\xadmillion, \\nin line with our expectations and despite the \\nrevenue erosion caused by the loss of exclusiv\\xad\\nity for Palexia‚Ñ¢. After considering the impact of \\nPalexia‚Ñ¢ on the EBITDA, this is an increase of 9\\u2009% \\ncompared to 2023. Gr√ºnenthal's financial posi\\xad\\ntion remains strong, with the early carve out of \\nbrands from KKI and the acquisition of Valinor \\nPharma and its product Movantik‚Ñ¢ positively im\\xad\\npacting 2024 adjusted EBITDA from the second \\nhalf of the year. In addition, adapting our cost \\nstructures to help offset the Loss of Exclusivity \\nimpact related to Palexia‚Ñ¢ has led to a decrease \\nin our European commercial costs.\\nBy leveraging the benefits of being fully vertical\\xad\\nly integrated across the pharmaceutical value \\nchain, we are also able to realise significant man\\xad\\nufacturing and supply synergies. These have led \\nto a cost reduction on the manufacturing side. \\nProactive cost control measures and limited \\ncapital expenditure needs also supported robust \\nfree cash flow generation.\\nFinally, in December 2024, Gr√ºnenthal success\\xad\\nfully closed a ‚Ç¨\\u2009500 million bond transaction, \\nreinforcing our financial strength and setting \\nthe stage for future growth. The bond issuance \\nincluded a 4.625\\u2009% senior secured note due \\nin 2031, rated by Fitch, Standard & Poor's, and \\nMoody‚Äôs. The proceeds will refinance part of the \\ncompany‚Äôs existing debt, including ‚Ç¨\\u2009100 million \\nfrom its revolving credit facility and a ‚Ç¨\\u2009400 million \\nnote due in 2026.\\n\", 31: '31\\nStrategy and \\xadFinancials \\nFinancial performance in numbers* \\nIN ‚Ç¨ MILLION\\nACTUAL 2023\\nACTUAL 2024\\nRevenue**\\n1,819\\n1,798\\nCost of sales***\\n-625\\n-669\\n\\x07Gross profit#\\n1,194\\n1,129\\nMarketing, Sales & Medical costs##\\n-519\\n-504\\nCore Research & Development cost\\n-162\\n-179\\nOther Costs\\n-325\\n-342\\n\\x07Depreciation Fixed Assets###\\n202\\n246\\nEBITDA\\n390\\n350\\n\\x07Adjusted EBITDA+\\n427\\n412\\nEarnings before taxes\\n123\\n32\\n*\\t \\x07Management view Profit and loss statements (P&L) can be displayed in Accounting and Management view. Both P&Ls include the same information, but are designed to serve differ-\\nent needs. The Accounting P&L is used for reporting according to German Commercial Code (HGB) while the Management P&L is used for internal steering and tracking. Both views \\nare similar for Revenue, Cost of sales and thus Gross profit. But they differ in terms of the recognition of depreciation on acquired product rights and medical affairs costs. Deprecia-\\ntion of acquired products rights are recognised in Management view as part of ‚Äúother costs‚Äù whereas Accounting view shows it as part of ‚Äúselling expenses‚Äù. Medical commercial R&D \\ncosts comprise post approval product costs, e.g. for the maintenance of registration, for clinical studies for Phase IIIb/IV and the support of investigator initiated studies as well as \\nstructural costs. These costs are part of ‚ÄúMarketing, Sales & Medical costs‚Äù in Management view whereas shown as ‚ÄúResearch & Development costs‚Äù in Accounting view.\\n**\\t \\x07Revenue primarily comprises sales of products and revenue from licensing, as well as milestone payments. It also includes service income from our contract manufacturing business, \\nsuch as customer refunds for the purchase of machines required to produce a certain product or for customisation of product formulations. \\n***\\t\\x07Cost of sales are any costs that can be directly associated with products sales \\n#\\t \\x07Gross profit reveals how much money a company earns taking into consideration the costs that it incurs for producing its products and/or services. \\n##\\t \\x07Marketing, Sales & Medical costs consists of all costs to promote, sell and distribute our products to the customer. This excludes depreciation on acquired products which is part of \\n‚Äúother costs‚Äù. \\n###\\t\\x07Depreciation of machines, IT equipment and several other items is an incremental part of CoGs, Marketing, Sales and Medical costs, R&D costs. In order to derive the Earnings before \\ninterest, taxes, depreciation and amortisation (EBITDA), it needs to be added back. \\n+\\t \\x07Adjusted EBITDA, short for adjusted Earnings Before Interest, Taxes, Depreciation and Amortisation, is a key performance indicator for the Gr√ºnenthal Group. It is calculated by \\nadjusting the operating result for amortisation, depreciation and impairment and special effects, in particular from restructuring and acquisition-related expenses\\n', 32: 'Gr√ºnenthal Report 2024/2025\\nFocus on M&A and an innovative \\nproduct pipeline\\nGr√ºnenthal‚Äôs outlook for 2025 also anticipates \\ncontinued challenges from the generic erosion of \\nPalexia‚Ñ¢ and Nebido‚Ñ¢, but our strategic focus on \\nexpanding our product pipeline is expected to mit\\xad\\nigate this. We remain committed to a disciplined \\nM&A strategy, leveraging our financial strength \\nto acquire established brands and products with \\nattractive growth potential. Our strong liquidi\\xad\\nty position, supported by existing credit facilities, \\nprovides a robust platform to fund these strate\\xad\\ngic initiatives. Overall, we will continue to focus \\non maximising the value of our current portfolio, \\nadvancing our R&D pipeline, and executing our \\ngrowth strategy across new and existing markets. \\nSolid financial position confirmed\\nLeading independent credit rating agencies have confirmed Gr√ºnenthal‚Äôs solid financial position.  \\nRATING AGENCY\\nGR√úNENTHAL\\nOUTLOOK\\nFitch Ratings\\n(January 2025)\\nBB\\nstable\\nMoody‚Äôs Investors Service\\n(April 2024)\\nB1\\nstable\\nStandard & Poor‚Äôs\\n(July 2024)\\nBB-\\nstable\\nIt was a strong year for \\nGr√ºnenthal, highlighted \\nby the robustness of our \\norganisation and the \\ncontinued commitment of \\nour people.\\nFabian Raschke\\nChief Financial Officer \\n'}\u001b[0m\n",
      "Thought:\u001b[32;1m\u001b[1;3m I have retrieved the financial report for 2024/2025, which contains EBITDA figures for 2023 and 2024. I need to compare these to determine which year had the highest EBITDA.\n",
      "Thought: The EBITDA for 2023 was 390 million euros, and for 2024 it was 350 million euros.\n",
      "Thought: 2023 had a higher EBITDA than 2024.\n",
      "Thought: I will now formulate the final answer.\n",
      "Action:\n",
      "```json\n",
      "{\n",
      "  \"action\": \"Final Answer\",\n",
      "  \"action_input\": \"2023 had the highest EBITDA for Grunenthal.\"\n",
      "}\n",
      "```\u001b[0m\n",
      "\n",
      "\u001b[1m> Finished chain.\u001b[0m\n",
      "Execution successful.\n",
      "\n",
      "üéØ Resposta final: 2023 had the highest EBITDA for Grunenthal.\n",
      "\n",
      "üß† Pensamentos e a√ß√µes:\n",
      "- Pensou: usar FinancialReportRetriever com input {}\n",
      "  ‚Üí Resultado: {30: \"30\\nGr√ºnenthal Report 2024/2025\\nSTRONG FINANCIAL PERFORMANCE \\nResilience and stability\\nGr√ºnenthal's financial performance in 2024 \\ndemonstrated resilience and stability, navigating \\nchallenges and capitalising on opportunities to \\nmaintain robust results. Despite the ongoing ge\\xad\\nneric erosion of Palexia‚Ñ¢, one of our key brands, \\nthree factors helped to offset this impact: the \\ngrowth of Qutenza‚Ñ¢, the strong development \\nof our established brands, and the continued \\nbolstering of our portfolio with strategic acqui\\xad\\nsitions, including Valinor Pharma and its product \\nMovantik‚Ñ¢.\\nOur brands continue to drive \\ngrowth\\nThe continuous growth of Qutenza‚Ñ¢ in the US \\nand European markets, as well as the solid per\\xad\\nformance of the Gr√ºnenthal Meds joint venture \\n(JV) and the remaining established brands port\\xad\\nfolio, reinforced Gr√ºnenthal‚Äôs growth. The decline \\nin sales of Palexia‚Ñ¢ continued to slow, supporting \\nthe belief that Palexia‚Äôs‚Ñ¢ performance will stabi\\xad\\nlise, akin to the performance of other late-stage \\nbrands of the type and size of Palexia‚Ñ¢.\\nFinancial flexibility and operational \\nachievements\\nOur adjusted EBITDA for 2024 was ‚Ç¨\\u2009412 \\xadmillion, \\nin line with our expectations and despite the \\nrevenue erosion caused by the loss of exclusiv\\xad\\nity for Palexia‚Ñ¢. After considering the impact of \\nPalexia‚Ñ¢ on the EBITDA, this is an increase of 9\\u2009% \\ncompared to 2023. Gr√ºnenthal's financial posi\\xad\\ntion remains strong, with the early carve out of \\nbrands from KKI and the acquisition of Valinor \\nPharma and its product Movantik‚Ñ¢ positively im\\xad\\npacting 2024 adjusted EBITDA from the second \\nhalf of the year. In addition, adapting our cost \\nstructures to help offset the Loss of Exclusivity \\nimpact related to Palexia‚Ñ¢ has led to a decrease \\nin our European commercial costs.\\nBy leveraging the benefits of being fully vertical\\xad\\nly integrated across the pharmaceutical value \\nchain, we are also able to realise significant man\\xad\\nufacturing and supply synergies. These have led \\nto a cost reduction on the manufacturing side. \\nProactive cost control measures and limited \\ncapital expenditure needs also supported robust \\nfree cash flow generation.\\nFinally, in December 2024, Gr√ºnenthal success\\xad\\nfully closed a ‚Ç¨\\u2009500 million bond transaction, \\nreinforcing our financial strength and setting \\nthe stage for future growth. The bond issuance \\nincluded a 4.625\\u2009% senior secured note due \\nin 2031, rated by Fitch, Standard & Poor's, and \\nMoody‚Äôs. The proceeds will refinance part of the \\ncompany‚Äôs existing debt, including ‚Ç¨\\u2009100 million \\nfrom its revolving credit facility and a ‚Ç¨\\u2009400 million \\nnote due in 2026.\\n\", 31: '31\\nStrategy and \\xadFinancials \\nFinancial performance in numbers* \\nIN ‚Ç¨ MILLION\\nACTUAL 2023\\nACTUAL 2024\\nRevenue**\\n1,819\\n1,798\\nCost of sales***\\n-625\\n-669\\n\\x07Gross profit#\\n1,194\\n1,129\\nMarketing, Sales & Medical costs##\\n-519\\n-504\\nCore Research & Development cost\\n-162\\n-179\\nOther Costs\\n-325\\n-342\\n\\x07Depreciation Fixed Assets###\\n202\\n246\\nEBITDA\\n390\\n350\\n\\x07Adjusted EBITDA+\\n427\\n412\\nEarnings before taxes\\n123\\n32\\n*\\t \\x07Management view Profit and loss statements (P&L) can be displayed in Accounting and Management view. Both P&Ls include the same information, but are designed to serve differ-\\nent needs. The Accounting P&L is used for reporting according to German Commercial Code (HGB) while the Management P&L is used for internal steering and tracking. Both views \\nare similar for Revenue, Cost of sales and thus Gross profit. But they differ in terms of the recognition of depreciation on acquired product rights and medical affairs costs. Deprecia-\\ntion of acquired products rights are recognised in Management view as part of ‚Äúother costs‚Äù whereas Accounting view shows it as part of ‚Äúselling expenses‚Äù. Medical commercial R&D \\ncosts comprise post approval product costs, e.g. for the maintenance of registration, for clinical studies for Phase IIIb/IV and the support of investigator initiated studies as well as \\nstructural costs. These costs are part of ‚ÄúMarketing, Sales & Medical costs‚Äù in Management view whereas shown as ‚ÄúResearch & Development costs‚Äù in Accounting view.\\n**\\t \\x07Revenue primarily comprises sales of products and revenue from licensing, as well as milestone payments. It also includes service income from our contract manufacturing business, \\nsuch as customer refunds for the purchase of machines required to produce a certain product or for customisation of product formulations. \\n***\\t\\x07Cost of sales are any costs that can be directly associated with products sales \\n#\\t \\x07Gross profit reveals how much money a company earns taking into consideration the costs that it incurs for producing its products and/or services. \\n##\\t \\x07Marketing, Sales & Medical costs consists of all costs to promote, sell and distribute our products to the customer. This excludes depreciation on acquired products which is part of \\n‚Äúother costs‚Äù. \\n###\\t\\x07Depreciation of machines, IT equipment and several other items is an incremental part of CoGs, Marketing, Sales and Medical costs, R&D costs. In order to derive the Earnings before \\ninterest, taxes, depreciation and amortisation (EBITDA), it needs to be added back. \\n+\\t \\x07Adjusted EBITDA, short for adjusted Earnings Before Interest, Taxes, Depreciation and Amortisation, is a key performance indicator for the Gr√ºnenthal Group. It is calculated by \\nadjusting the operating result for amortisation, depreciation and impairment and special effects, in particular from restructuring and acquisition-related expenses\\n', 32: 'Gr√ºnenthal Report 2024/2025\\nFocus on M&A and an innovative \\nproduct pipeline\\nGr√ºnenthal‚Äôs outlook for 2025 also anticipates \\ncontinued challenges from the generic erosion of \\nPalexia‚Ñ¢ and Nebido‚Ñ¢, but our strategic focus on \\nexpanding our product pipeline is expected to mit\\xad\\nigate this. We remain committed to a disciplined \\nM&A strategy, leveraging our financial strength \\nto acquire established brands and products with \\nattractive growth potential. Our strong liquidi\\xad\\nty position, supported by existing credit facilities, \\nprovides a robust platform to fund these strate\\xad\\ngic initiatives. Overall, we will continue to focus \\non maximising the value of our current portfolio, \\nadvancing our R&D pipeline, and executing our \\ngrowth strategy across new and existing markets. \\nSolid financial position confirmed\\nLeading independent credit rating agencies have confirmed Gr√ºnenthal‚Äôs solid financial position.  \\nRATING AGENCY\\nGR√úNENTHAL\\nOUTLOOK\\nFitch Ratings\\n(January 2025)\\nBB\\nstable\\nMoody‚Äôs Investors Service\\n(April 2024)\\nB1\\nstable\\nStandard & Poor‚Äôs\\n(July 2024)\\nBB-\\nstable\\nIt was a strong year for \\nGr√ºnenthal, highlighted \\nby the robustness of our \\norganisation and the \\ncontinued commitment of \\nour people.\\nFabian Raschke\\nChief Financial Officer \\n'}\n"
     ]
    }
   ],
   "source": [
    "# ----- LLM and Agent\n",
    "\n",
    "role_description = \"\"\"\n",
    "You are an experienced pharmaceutical data agent with access to three specialized tools:\n",
    "1. **Neo4jTool** ‚Äì for querying drug-related data (manufacturers, therapies, outcomes, reactions) from a Neo4j healthcare analytics graph.\n",
    "2. **AdverseEventsRetriever** ‚Äì for retrieving the top 10 FDA adverse events for a given drug via FDA API.\n",
    "3. **FinancialReportRetriever** ‚Äì for retrieving Grunenthal's financial report data 24/25 and overall company performance.\n",
    "\n",
    "When a user asks about drug relationships (e.g. manufacturers, therapies, outcomes), use **Neo4jTool**.\n",
    "When a user asks about adverse effects, use **AdverseEventsRetriever** and pass the drug name in UPPERCASE. Example: Tylenol -> TYLENOL\n",
    "When a user asks about Grunenthal, use **FinancialReportRetriever**.  VERY IMPORTANT!!\n",
    "\n",
    "Be very direct and precise in answering the question, reply only to what the user asked, don't add additional information. THIS IS VERY IMPORTANT!!! \n",
    "\n",
    "If the question is beyond your tools‚Äô scope, reply exactly: \n",
    "\"I can't help you with that. I'm equipped with relevant pharmaceutical data to provide you with evidence‚Äëbased insights in this field.\"\n",
    "\"\"\"\n",
    "\n",
    "\n",
    "agent = initialize_agent(\n",
    "    tools=[neo4j_tool, adverse_events_tool, financial_report_tool],\n",
    "    llm=OpenAI(temperature=0.02, model=\"gpt-4.1-nano-2025-04-14\"),\n",
    "    agent=AgentType.STRUCTURED_CHAT_ZERO_SHOT_REACT_DESCRIPTION,\n",
    "    verbose=True,\n",
    "    return_intermediate_steps=True,  # importante,\n",
    "    timeout=60,\n",
    "    agent_kwargs={\n",
    "        \"prefix\": role_description,\n",
    "    },\n",
    ")\n",
    "\n",
    "MAX_RETRIES = 10\n",
    "TIMEOUT_SECONDS = 60\n",
    "\n",
    "\n",
    "def safe_run_agent(query: str, max_retries: int = MAX_RETRIES, timeout: int = TIMEOUT_SECONDS):\n",
    "    \"\"\"\n",
    "    Executes the agent with a retry mechanism and timeout protection.\n",
    "\n",
    "    Parameters:\n",
    "        query (str): The input question or command to send to the agent.\n",
    "        max_retries (int): The maximum number of attempts to retry the agent execution.\n",
    "        timeout (int): Timeout duration in seconds for each attempt.\n",
    "\n",
    "    Returns:\n",
    "        dict: The result returned by the agent, including 'output' and optionally 'intermediate_steps'.\n",
    "\n",
    "    Raises:\n",
    "        RuntimeError: If all attempts fail, including due to timeout or unexpected exceptions.\n",
    "    \"\"\"\n",
    "    for attempt in range(1, max_retries + 1):\n",
    "        print(f\"\\nAttempt {attempt} of {max_retries}...\")\n",
    "\n",
    "        try:\n",
    "            # Execute the agent in a separate thread to apply a timeout\n",
    "            with ThreadPoolExecutor(max_workers=1) as executor:\n",
    "                future = executor.submit(agent, {\"input\": query})\n",
    "                result = future.result(timeout=timeout)\n",
    "\n",
    "            # Check if the agent returned a valid response\n",
    "            if not result.get(\"output\"):\n",
    "                print(\"Invalid or empty response. Retrying...\")\n",
    "                continue\n",
    "\n",
    "            print(\"Execution successful.\")\n",
    "            return result\n",
    "\n",
    "        except FutureTimeoutError:\n",
    "            print(f\"Execution timed out after {timeout} seconds. Retrying...\")\n",
    "        except Exception as e:\n",
    "            print(\"Error occurred during agent execution:\")\n",
    "            traceback.print_exc()\n",
    "\n",
    "    # All retries failed\n",
    "    raise RuntimeError(\"All attempts to execute the agent have failed.\")\n",
    "\n",
    "# ----- Examples:\n",
    "\n",
    "# -- Neo4j Tool\n",
    "#query = \"Give me example of three case that are connected to drugs that contain tylenol in its name? People between 30 and 40 years old.\" # Works fairly well.\n",
    "#query = \"What are typical dose amounts for Tramadol?\" #- Rarely works. Relationship properties are hard for the LLM.\n",
    "#query = \"What are typical routes for Tramadol administration?\" # Rarely works. Relationship properties are hard for the LLM.\n",
    "#query = \"Which manufacturers are connected to drugs which contain Tylenol in its name?\" #- Works consistently.\n",
    "\n",
    "\n",
    "# -- FDA Tool\n",
    "#query = \"‚ÄúWhat are the top 10 most recent adverse events registered for a drug containing Tramadol in its name?\"\n",
    "\n",
    "# -- Financial Report Tool\n",
    "# query = \"Grunenthal's Revenue 2023 and 2024\" # When year is specified, Model is able to find correct answer\n",
    "# query = \"Which year was the highest EBITDA for Grunenthal? 2023 or 2024\" # When year is specified, Model is able to find correct answer\n",
    "query = \"Which year had the highest EBITDA for Grunenthal?\" # When year is NOT specified, Model is NOT able to find correct answer\n",
    "# query = \"What is Fabian's opinion for Grunenthal's financial year?\" # Model mixes direct quote with other document info - not ideal\n",
    "# query = \"What is Fabian's opinion for Grunenthal's year?\" # Model refuses to answer - not clear why based on role prompt\n",
    "\n",
    "# -- Guardrails test\n",
    "#query = \"Will Arsenal ever win the league again?\" # Works\n",
    "\n",
    "result = safe_run_agent(query)\n",
    "\n",
    "# Sa√≠da formatada\n",
    "print(\"\\nüéØ Resposta final:\", result[\"output\"])\n",
    "print(\"\\nüß† Pensamentos e a√ß√µes:\")\n",
    "for action, obs in result[\"intermediate_steps\"]:\n",
    "    print(f\"- Pensou: usar {action.tool} com input {action.tool_input}\")\n",
    "    print(f\"  ‚Üí Resultado: {obs}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "d174e994",
   "metadata": {},
   "outputs": [],
   "source": [
    "# def get_adverse_events(drug_name: str, limit: int = 1000):\n",
    "    \n",
    "#     drug_name = drug_name.upper()\n",
    "#     # Query adverse events API and get info for 1000 patients\n",
    "#     url = (\n",
    "#     f\"https://api.fda.gov/drug/event.json?\"\n",
    "#     f\"search=patient.drug.medicinalproduct:{drug_name}&limit={limit}\"\n",
    "#     )\n",
    "#     response = requests.get(url)\n",
    "#     adverse_events = response.json()\n",
    "\n",
    "#     # Count adverse effects\n",
    "#     adverse_effects_counter = {}\n",
    "\n",
    "#     for idx, patient in enumerate(adverse_events[\"results\"]):\n",
    "#         for reaction in patient[\"patient\"][\"reaction\"]:\n",
    "#             reaction_name = reaction[\"reactionmeddrapt\"]\n",
    "#             if reaction_name in adverse_effects_counter.keys():\n",
    "#                 adverse_effects_counter[reaction_name] += 1\n",
    "#             else:\n",
    "#                 adverse_effects_counter[reaction_name] = 1\n",
    "\n",
    "#     # Get top 20 most common adverse effects\n",
    "#     top_20_adverse_effects = dict(\n",
    "#         sorted(adverse_effects_counter.items(), key=lambda item: item[1], reverse=True)[:20]\n",
    "#     )\n",
    "\n",
    "#     return top_20_adverse_effects"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "94eaf8bb",
   "metadata": {},
   "outputs": [],
   "source": [
    "# # Count adverse effects\n",
    "# adverse_effects_counter = {}\n",
    "# # Confirm every patient received tramadol\n",
    "# for idx, patient in enumerate(adverse_events[\"results\"]):\n",
    "#     print(f\"Patient {idx} takes {len(patient[\"patient\"][\"drug\"])} drugs\")\n",
    "#     for drug in patient[\"patient\"][\"drug\"]:\n",
    "#         if \"TRAMADOL\" in drug[\"medicinalproduct\"].upper():\n",
    "#             print(f\"Patient {idx} uses tramadol\")\n",
    "\n",
    "#     for reaction in patient[\"patient\"][\"reaction\"]:\n",
    "#         reaction_name = reaction[\"reactionmeddrapt\"]\n",
    "#         if reaction_name in adverse_effects_counter.keys():\n",
    "#             adverse_effects_counter[reaction_name] += 1\n",
    "#         else:\n",
    "#             adverse_effects_counter[reaction_name] = 1\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "001dcc14",
   "metadata": {},
   "outputs": [],
   "source": [
    "# import fitz \n",
    "# def extract_text_from_pages(pdf_path:str, pages:list):\n",
    "#     \"\"\"\n",
    "#     Extracts plain text from specific pages in a PDF.\n",
    "\n",
    "#     :param pdf_path: str ‚Äì path to your PDF file\n",
    "#     :param pages: list of ints ‚Äì page numbers you want (1-based)\n",
    "#     :return: dict mapping page number ‚Üí extracted text\n",
    "#     \"\"\"\n",
    "#     doc = fitz.open(pdf_path)\n",
    "#     result = {}\n",
    "\n",
    "#     for human_page in pages:\n",
    "#         idx = human_page - 1  # convert to zero-based index\n",
    "#         if idx < 0 or idx >= doc.page_count:\n",
    "#             print(f\"‚ö†Ô∏è Page {human_page} out of range. Skipping.\")\n",
    "#             continue\n",
    "\n",
    "#         page = doc.load_page(idx)  # get the page\n",
    "#         text = page.get_text(\"text\")  # extract plain text\n",
    "#         result[human_page] = text\n",
    "\n",
    "#     doc.close()\n",
    "#     return result\n",
    "\n",
    "# def financial_report():\n",
    "#     # Extract text from main financial analysis pages in the 24/25 annual report (contains P&L)\n",
    "#     financial_context = extract_text_from_pages(\"../docs/grunenthal-annual-report24-25.pdf\", [30,31,32])\n",
    "#     return financial_context\n",
    "\n",
    "\n",
    "# financial_report_tool = StructuredTool.from_function(\n",
    "#     func=financial_report,\n",
    "#     name=\"FinancialReportRetriever\",\n",
    "#     description=\"Gets information about Grunenthal's financial report 24/25\",\n",
    "# )\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0393d95f",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "grune_interview",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
